Abstract:BACKGROUND:An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel antimicrobial agents.OBJECTIVE:As a part of our ongoing studies toward the development of novel antibacterial agents, the synthesis and antibacterial activity of a series of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives will be discussed in this study.METHOD:(Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives were designed, synthesized and evaluated for antibacterial activity. The structures were confirmed by IR, 1H NMR, 13C NMR and mass spectrometry. All of the synthesized compounds were evaluated in vitro using a 96-well microtiter plate and a serial dilution method to obtain their minimum inhibitory concentration (MIC) values against a variety of different strains, including multidrug-resistant clinical isolates.RESULTS:The antibacterial test in-vitro showed that most compounds in series 7 and 9 exhibited significant inhibitory activities against anaerobic bacteria (Streptococcus mutans) strains with a MIC value of 1 µg/mL. Compounds 7c and 9c showed the most potent activity against MRSA (3167 and 3506) with a minimum inhibitory concentration (MIC) value of 1 µg/mL, which is equivalent to moxifloxacin and greater than gatifloxacin, oxacillin and norfloxacin. Additionally, compound 9c showed potent antibacterial activity against Bacillus subtilis (aerobic bacteria) with a MIC value of 2 µg/mL.CONCLUSION:The work suggests that these type of rhodanine compounds had a better potent activity against MRSA compared with other perviously reported rhodanine derivatives, which might provide a valuable information for the development of new antibacterial agents against multidrug-resistant clinical isolates MRSA.

Synthesis and Anti-infective Potency Study of Ru-based Complex bearing Benzonitrile against Staphylococcus aureus

Synthesis and in vitro Antibacterial Activities of Some Bis-Oxazolidinones

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Synthesis and antibacterial against S. aureus of new ruthenium (II) polypyridine complexes containing pyrene groups

Polypyridyl ruthenium complexes with benzothiazole moiety as membrane disruptors and anti-resistance agents for Staphylococcus aureus

Ruthenium polypyridine complexes with triphenylamine groups as antibacterial agents against Staphylococcus aureus with membrane-disruptive mechanism

Novel Benzothiazole‒urea Hybrids: Design, Synthesis and Biological Activity As Potent Anti-Bacterial Agents Against MRSA.

Targeting Bacterial Efflux Pump Effectively Enhances the Efficacy of Ru-based Antibacterial Agents Against Gram-negative Pathogen

Morpholine-modified Ru-based agents with multiple antibacterial mechanisms as metalloantibiotic candidates against Staphylococcus aureus infection

In vitro evaluation of novel Ru (II) complexes of thiazolhidrazinylidene-chroman-2,4-diones for their potential antibacterial activity

Novel Benzyl Phenyl Sulfide Derivatives As Antibacterial Agents Against Methicillin-Resistant Staphylococcus Aureus

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

Ruthenium polypyridine complexes containing prenyl groups as antibacterial agents against Staphylococcus aureus through a membrane‐disruption mechanism

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

Design, Synthesis, in Vitro and in Vivo Evaluation and Molecular Docking Study of Novel Pleuromutilin Derivatives As Antibacterial Agents

Synthesis and Antibacterial Activity of Novel Triazolo[4,3-a]pyrazine Derivatives

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-oxazolidinone Derivatives As Antibacterial Agents.

Design, Synthesis of Novel 4,5-Dihydroisoxazole-containing Benzamide Derivatives As Highly Potent FtsZ Inhibitors Capable of Killing a Variety of MDR Staphylococcus Aureus.

Ruthenium terpyridine complexes based on dppz ligands as photodynamic antimicrobial agents against Staphylococcus aureus

Novel Schiff Base‐conjugated para ‐Aminobenzenesulfonamide Indole Hybrids as Potentially Muti‐targeting Blockers against Staphylococcus aureus